Extract

Primary objective : - To demonstrate the antidepressant efficacy on the Hamilton Depression Rating Scale of SR58611A 700mg/day compared with placebo in the treatment of patients with a recurrent major depressive episode. Secondary objectives: - To assess the safety profile of SR58611A 700 mg/d in comparison to placebo and to assess plasma concentrations of the active metabolite.

Inclusion criteria

• Major Depressive Disorders

Country

• Bulgaria
• Croatia
• Czech Republic
• Estonia
• France
• Montenegro
• Netherlands
• Serbia

Links

• ictrp
• nct